Sintx Technologies (NASDAQ:SINT – Get Free Report) and SiBone (NASDAQ:SIBN – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, institutional ownership, profitability, earnings and risk.
Profitability
This table compares Sintx Technologies and SiBone’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Sintx Technologies | -848.20% | -354.44% | -115.37% |
| SiBone | -6.85% | -8.23% | -6.07% |
Earnings & Valuation
This table compares Sintx Technologies and SiBone”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Sintx Technologies | $1.02 million | 6.48 | -$10.36 million | ($4.91) | -0.31 |
| SiBone | $200.93 million | 4.30 | -$18.90 million | ($0.34) | -57.26 |
Sintx Technologies has higher earnings, but lower revenue than SiBone. SiBone is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 98.1% of SiBone shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by company insiders. Comparatively, 4.0% of SiBone shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Sintx Technologies and SiBone, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Sintx Technologies | 1 | 0 | 3 | 0 | 2.50 |
| SiBone | 1 | 0 | 6 | 0 | 2.71 |
Sintx Technologies currently has a consensus target price of $9.33, indicating a potential upside of 510.02%. SiBone has a consensus target price of $24.17, indicating a potential upside of 24.12%. Given Sintx Technologies’ higher probable upside, research analysts clearly believe Sintx Technologies is more favorable than SiBone.
Volatility & Risk
Sintx Technologies has a beta of 0.62, suggesting that its stock price is 38% less volatile than the S&P 500. Comparatively, SiBone has a beta of 0.66, suggesting that its stock price is 34% less volatile than the S&P 500.
Summary
SiBone beats Sintx Technologies on 9 of the 14 factors compared between the two stocks.
About Sintx Technologies
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
About SiBone
SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
